Courtesy pink.pharmaintelligence.informa.com
A drug which doctors often prescribe to treat blood cancer might come in handy in the treatment of COVID-19.
According to scientists, cancer drug acalabrutinib – which is associated with reduced respiratory distress – can bring down the overactive immune response in COVID-19 patients.
Researchers at National Cancer Institute in the US say that acalabrutinib blocked the protein Bruton yrosine kinase (BTK) in COVID-19 patients and clinically benefitted some of them.
Hence it is a potential therapeutic for the novel coronavirus disease, which has killed 399,000 people across the world so far.
The study included 19 patients diagnosed with coronavirus who required hospitalisation. Eight had been on ventilators for a day or two, of whom four came out of it and were eventually discharged.
Two of the patients in this group died.
Published in the journal Science Immunology, the study observed that the findings should not be considered clinical advice, as it remains to be tested in a randomised, controlled clinical trial.
New Delhi: As part of preparations for a trip to Nainital, a man ordered a pack…
New Delhi: Actress Priyanka Chopra’s recent Instagram post has sparked speculation about a possible crossover…
Berhampur: Renowned pulmonologist of Odisha Dr Narayan Mishra honoured with the prestigious ‘Indian Chest Society-Lifetime…
Mumbai: Two crew members of a fishing vessel have been missing since it collided with…
Raipur: In a major operation, security forces eliminated at least 10 Maoists in an encounter in…
Bhubaneswar: Experts from across India and abroad exchanged knowledge and ideas on latest developments in…
Cuttack Sadar MLA Prakash Sethi's English speech at Bali Jatra inauguration has gone Viral......the caption…
Bhubaneswar: A day after 125th birth anniversary celebration of Harekrushna Mahtab was inaugurated, a war…